News for 'bristol-myers-squibb'

Rare-Disease, Cancer Drugs Get Cheaper

For patients, the immediate impact is a reduction in the final cost of therapies that often run into lakhs per month.

Modi urges global tech CEOs to be part of India growth story

Prime Minister Narendra Modi urged CEOs of US majors to take advantage of India's growth story as the country is making all efforts to become the third largest economy of the world in his third term. India is currently the fifth largest economy of the world after the US, China, Germany and Japan with a GDP of around $3.9 trillion. India has been the fastest growing large economies of the world with GDP growth rate of over 7 per cent for the last three consecutive years.

'Real growth and opportunity are going to come from GLP-1'

'It is not just the US and European opportunity, but it is a huge global opportunity.'

He BLEW the whistle on Ranbaxy and got Rs 268 crore

Dinesh Thakur says he waved the red flag only after Ranbaxy didn't respond to his concerns.

MNCs still bullish on India R&D

Even as some major global pharmaceutical majors like Novartis say India's patent laws are weak and a hurdle to their investment plans for the country

Ranbaxy buys rights for skin products from BMS

Continuing with its push in the US market, Ranbaxy Laboratories said on Monday it has acquired the marketing rights for 13 skincare products from Bristol-Myers Squibb Company for $26 million.

Ranbaxy acquires US rights for 13 brands

Ranbaxy earned $114 million from its US operations in 2006. It launched 10 new products during the year. The company said that the revenues from the sale of the newly acquired brands would be reflected from the next quarter.

MNC pharma firms eyeing duty relief

Eli Lily, Sanofi Aventis, Bristol Myers approach chemicals ministry.

Ranbaxy bags cardio drug deal

Who could replace Peter Dolan?

Bristol-Myers rolls out hepatitis B drug

Aurobindo to sell Bristol AIDS drugs

Aurobindo Pharma has received licences from Bristol Myers Squibb Co to market two anti-AIDS drugs in 49 countries.

BMS strategy for new Hepatitis drug

Bristol-Myers plans to set up shop in India

Reddy's get US FDA nod for drug

Wait for cheaper drugs might get longer

Lobby group tells USTR it has got assurance from India on compulsory licensing.

India won't participate in US probe on IPR

India is not so keen to co-operate with the US on IPR related probe.

US leaders to woo Indian industry amid trade spat

Delegation visit ahead of patent law report.

India, US to enhance engagement on IPR

India and the US on Sunday agreed to enhance their engagement on intellectual property rights, a vexed issue between the two countries.

Sensex ends below 24,000 on Asia meltdown, oil woes

Sensex lost 184 points to trade at 23,878 and the Nifty has dropped 55 points to quote at 7,254.

World's 10 best performing CEOs

Amazon CEO Jeff Bezos has been ranked as the world's best performing CEO.